Why New Jersey Should Be Your New Home For Pharma & Bio
In 1998 New Jersey had 80 biotechnology firms. Today there are over 350. The state is also home to 23 large pharmaceutical firms including Sanofi, Bristol-Myers Squibb, Merck, Johnson & Johnson, and Novartis, as well as numerous medical device companies. If you look at the life science industry as a whole, the U.S. Department of Labor lists more than 1,000 firms located in the state. While many states would be happy with those numbers, many in New Jersey, from the governor’s office on down, will tell you they want more. At the 2013 Bio International Conference, New Jersey representatives made it clear they will continue to do their best to solidify the state’s role as the largest pharmaceutical hub in the nation and third in biotechnology.
India’s CDSCO Calls For GDP Compliance To Safeguard Pharmaceutical Supply Chain
The Central Drugs Standard Control Organization (CDSCO), the national regulatory body governing pharmaceuticals and medical devices in India, issued draft guidelines earlier this year designed to ensure the quality and identity of pharmaceutical products throughout the distribution process. By Mark Bishop, World Courier
The FDA’s Clock Is Ticking – Why Those 15 Days Are Critical
When many companies respond to an FDA 483, they tend to address each specific violation in their response letter. Although they are addressing the individual complaints, they never actually get down to solving the underlying problems.
Developing a response letter that addresses the inspectional observations as well as the underlying problems has gotten more challenging. The agency is now putting more pressure on drug manufacturers to answer within 15 workdays after an inspection closes out. The clock is ticking, and your time is running out!
A Powerful Method To Develop Highly Concentrated Protein Formulations
Proteins perform an array of functions in living organisms, from structural scaffolds and signaling molecules to catalysts and cell-surface receptors. Structural perturbations and aberrant protein production are associated with many disease states, making these macromolecules potential candidates for pharmaceuticals. This strategy became a reality following the advent of recombinant DNA technologies, which allowed proteins to be produced on a large scale. Issues related to protein solubility can limit this approach, however, and drastically reduce the number of possible therapeutics that can be delivered to patients. “Solutions” to this problem are highly desirable.
FROM THE INDUSTRY EXPERTS
Preparing For The Physician's Payment Sunshine Act Of 2009 Over the past several year interactions between Health Care Providers (HCPs), Health Care Institutions (HCIs) and Life Science organizations (pharmaceutical and medical device) companies have been under increased scrutiny.
CLINICAL WHITE PAPERS AND CASE STUDIES
Regulatory Approval Of Clinical Studies In The Netherlands
The EU Clinical Trials Directive (CTD) has been fully implemented in the Netherlands.
Frost & Sullivan's GIL 2013: Europe Set the Stage for a More Positive Economic Outlook
Frost & Sullivan's GIL 2013: Europe - The Global Community of Growth, Innovation and Leadership annual congress, which set the stage for a new and more positive economic outlook which was confirmed yesterday by the encouraging predictions from the Bank of England.
Bio-STAR Technology Ensure that proper permits, site instructions and supplies are in place before the study begins.
Ensuring Quality And Balancing Risks For Multiregional Clinical Trials Join industry and regulatory leaders to address multiregional clinical trial (MRCT) opportunities and risks from a global perspective.
Clinical Outcome Assessments/ePRO
While certain aspects of your trial may be viewed as PRO, ClinRO or ObsRO, the most important output from your trial is data. As such, we offer you the ability to design and implement clinical programs that generate the highest quality data, be it from a patient, physician or caregiver.
SynteractHCR offers full-featured global Interactive Voice and Web Response Systems for your clinical trial operations, through our validated 21 CRF Part 11 compliant proprietary system. Once implemented, the system is available 24/7 for use by sites, study participants and project team members.
Global Clinical Trial Support
For over 20 years, TransPerfect has been a trusted name in global support services for leading life sciences companies and CROs. That same level of commitment and expertise is endemic in Trial Interactive's global clinical trial support offerings.
CoSign Connector For SharePoint
Organizations around the world and across industries have invested in Microsoft® SharePoint® for automating their business processes.
BioREAD Independent Image Review
BioREAD is a custom-designed system, developed by BioClinica which provides full image display capabilities for independent review of clinical trial imaging data.
CRO LEADERSHIP AWARD
CLINICAL BULLETIN BOARD
ARCHIVE NEWSLETTERMore Newsletters
ABOUT CLINICAL LEADER
Welcome to Clinical Leader, the premier online community that helps streamline clinical research by connecting trial sponsors and cutting edge service providers. In browsing the site, users can view and download a variety of industry-related content from our supplier directory, product showcase, and resource centers. This content is designed to help sponsors select potential partners and products to aid in clinical research.
VertMarkets Life Science Group has achieved an unparalleled reputation for the development, organization, and presentation of information for the pharmaceutical industry. Visitors are enriched with valuable information on CRO, Pre-Clinical Contract Research Organization, Bio-Analytical Contract Research Organization, Clinical Contract Research Organization, Pharmacovigilance, Clinical Data Management, Electronic Patient Reported Outcomes (ePRO), Point-of-Care Testing (POCT), Patient Recruitment, Electronic Data Capture (EDC), Clinical Trials Management Systems (CTMS) and more that can improve your business and make it more profitable.
ClinicalLeader.com will also publish a weekly newsletter containing the most up-to-date news and industry information. Please take a moment to join our community and discover the benefits of your free membership.